Substance Abuse, Addiction, and Treatment: Global Markets

 Published On: Aug, 2017 |    No of Pages: 150 |  Published By: BCC Research | Format: PDF
Request Free Sample
The global substance abuse and addiction treatment market reached $3.1 billion in 2016 and should reach nearly $4.4 billion in 2021, at a compound annual growth rate (CAGR) of 7.0%.

Report Includes

-An overview of the global market for substance abuse and addiction treatment therapeutics
-Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021
-Analyses of the market based on condition, treatment type, and region
-Discussion of the market dynamics, including drivers, restraints and opportunities
-An insight into the competitive landscape of the market through new product launches, mergers and acquisitions, and partnerships
-Profiles of the key players in the market

The factors fueling the growth of the substance abuse and addiction treatment market are the:

-Rising incidence of drug and alcohol abuse.
-Growing awareness of substance abuse among employers.
-Increasing number of accidents caused by driving under the influence (DUIs).
-Rising aging population leading to increased alcohol use, along with increased funding by the government and nongovernmental organizations.

Moreover, the formulation of stringent laws across various geographies and growing awareness in developing regions regarding the dangers of substance abuse are key factors in the expansion of the market for drug and alcohol addiction treatment. In 2014, Brazilís federal government passed a law that made it mandatory for professional drivers to pass a hair follicle drug test in order to apply for license renewal; this law, in turn, generates revenue for the substance abuse, addiction and treatment markets.

The association of tobacco use, drugs and alcohol with modern lifestyles in social and entertainment platforms may encourage substance abuse and addiction. The growing population base affected with the drug addiction along with rising health concerns due to drug abuse has led to the emergence of technically advanced and more sensitive drug tests and treatments, as well as more accurate drug screening devices, present growth opportunities for the providers in this market. But the limited effectiveness of the available treatment drugs is the key challenge facing industry stakeholders.

The substance abuse and addiction treatment market is segmented into the condition, treatment type, and geography. Conditions are further segmented into groups such as nicotine use, alcohol and drug abuse. The drug abuse subsegment is further categorized into opioid and cocaine abuse. The treatment market is segmented into Chantix, Zyban, detoxification, Campral, Antabuse, Dolophine (methadone), Suboxone and others. Geographically, the market is segmented into North America, Europe, Asia-Pacific and the Rest of World (ROW). The key players operating in this market are Pfizer, GlaxoSmithKline, Alkermes plc, Teva Pharmaceuticals, Reckitt Benckiser Pharmaceuticals and Forest Laboratories Inc.

Study Goals and Objectives

-Define as well as identify the key market segments and market structure of the substance abuse and addiction treatment market.
-Measure and estimate the global amount of substance abuse, addiction treatments and market segments, which include condition, treatment and geographic areas.
-Identify the key market dynamics and factors impacting global substance abuse and addiction treatment market and its subsegments.
-To identify the trends, gaps and opportunities in each segment of the industry.
-To focus exclusively on geographic segmentation, and to analyze trends and opportunities in the primary geographic regions: North America, Europe, Asia-Pacific and the ROW.
-To identify the major stakeholders, their product portfolios and recent developments, and describe the competitive landscape of the market leaders.

Reasons for Doing This Study

This research report presents an in-depth analysis of the global substance abuse and addiction treatment industry by condition or type of dependency, available treatments and geographic markets. The study includes the types of addiction requiring substance abuse and addiction treatment, and analyzes the clinical guidelines and drug testing laws within its respective regions. This investigation includes an in-depth analysis of the major companies operating in the global substance abuse and addiction treatment industry and provides a comprehensive analysis of drug abuse statistics. This report also focuses on drug testing-related trends in recent years covering different geographical regions such as the U.S., Europe and Japan.

Substance abuse and addiction treatment conditions are mainly segmented into nicotine, alcohol and drug abuse. Drug abuse is further categorized into opioid or cocaine abuse. The treatment market is further segmented by pharmaceutical options such as Chantix, Zyban, Campral, Antabuse, methadone, Suboxone and other medicines or detoxification treatment choices.

Scope of the Report

This report presents an in-depth analysis of the global substance abuse and addiction treatment market by conditions, treatments, and geographic markets; it includes the principal drug abuse conditions that are incorporated into several therapeutic treatment methods. This report examines the role of supply-chain members from manufacturers to researchers, and contains a comprehensive analysis of the dominant companies operating in the global substance abuse and addiction treatment market. The in-depth patent analysis section of the report will focus extensively on the technological trends across years and geographies such as the U.S., Europe and China.

This study considers the revenue generated by medications or therapeutics during the substance abuse treatment process. It does not review the expenses associated with services such as counseling, psychological therapy, rehabilitation or others. The report focuses on the substances that are either directly consumed or injected, hence the nicotine segment considers the medicines that help to treat smokeless tobacco addiction but does not take into account drugs that are only used for smoking cessation. The report examines all forms of opioids and cocaine in whichever form or mode they are ingested, and considers all types of alcohol abuse.

The market study is detailed for products based on applications as well as its further implication in the research and development area. These two segmentations are also discussed in depth for the given period. The market is broken down by the geographical regions of North America, Europe, Asia-Pacific and the ROW. Key market players operating in this market are Pfizer, GlaxoSmithKline, Alkermes, Teva Pharmaceuticals, Reckitt Benckiser, Forest Laboratories, and others totaling to about 20 companies.

Intended Audience

The intended audience of this report includes:

-Drug screening equipment and device manufacturers and potential entrants.
-The laboratories providing drug screening services to various end users.
-Dealers, distributors and service providers of drug screening products and drug abuse.
-Healthcare centers and rehabilitation centers providing addiction treatment.
-Healthcare service providers and private research institutes.
-Government authorities and public service boards.
-Research institutes, associations and academia.

Information Sources and Methodology

The global substance abuse and addiction treatment market was assessed and calculated through a bottom-up approach that involved identifying the revenues by each market segment. The following process was followed to ensure quality and consistency of the estimates:

-In-depth primary and secondary research was conducted.
-Primary research included gathering intelligence from key market players. The participants of these interviews included CEOs, key opinion leaders, product experts and directors.
-Secondary research not only included collation of data from freely available sources, but also by paid subscription from specialized industry magazines and websites.
-To best assure triangulation of market estimates, the derived values were again validated through primary research.
-Key factors considered during market estimations were price, volumes, incidence and prevalence rates, number of procedures, etc.
-The geographic segmentation was assessed through various parameters such as the number of players in a particular region, incidence and prevalence rates, and the extent of research activity occurring in that geography and future potential.

Geographic Breakdown

In this report, the geographic regions considered for market analysis include, and only include:

North America:
United States
Canada
Mexico

Europe:
Germany
France
United Kingdom
Italy
Spain
Russia
Others

Asia:
Australia
China
Japan
India
Others

Rest of World (ROW):
Latin America
Middle East
Africa
Chapter 1: Introduction 1
Study Goals and Objectives 1
Reasons for Doing This Study 2
Scope of the Report 2
Intended Audience 3
Information Sources and Methodology 3
Geographic Breakdown 3
Analystís Credentials 7
Related BCC Research Reports 7
Chapter 2: Summary and Highlights 9
Chapter 3: Global Substance Abuse and Addiction Treatment Market and
Technology Background 12
Substance Abuse and Addiction Treatment 12
Drug Testing Laws 13
Role of Drug Screening and Detection 14
Single- Versus Multiparameter Test 14
DOA Screening 14
Blood Testing 16
Oral Fluid Testing 16
Saliva Testing 16
Sweat Testing 16
Hair Testing 17
Testing Locations 17
Laboratory-Based Data 17
Criminal justice 18
Police 18
Prisons 18
Probation 18
Workplace Screening 19
Others 19
On-site Testing Versus Laboratory Testing 20
Side Effects of Substance Abuse and Role of Drug Screening in Detection 21
Injuries 21
Health Problems 21
Effects on the Brain 22
Drug, Nicotine and Alcohol Abuse Trends Among Youth 22
Survey by Age 23
Survey by Education and Current Employment Status 25
Future Prediction of Drug Screening and Drug Abuse 26
Immunoassay Analyzers 26
Chromatography Instruments 30
Breath Analyzers 33
Technology Trends 35
Rapid Testing Devices 35
Urine Testing Devices 37
Laboratory Services 38
Government Funding for Drug Testing, Illicit Drug Use, Alcohol Use, and Other Parameters Influencing
Market Growth 39
State-Funded Rehabilitation Centers 39
Clinical Guidelines 39
Handling Patients with Opioid Abuse 40
Overview of Captagon 40
Market Dynamics 43
Drivers 44
Restraints 46
Opportunities 47
Chapter 4: Global Substance Abuse and Addiction Treatment Market by Condition
49
Nicotine Abuse 49
Alcohol Abuse 50
Drug Abuse 51
Opioid Abuse 53
Cocaine Abuse 53
Chapter 5: Global Substance Abuse and Addiction Treatment Market by
Treatment Type 55
Chantix 55
Zyban 56
Detoxification Treatment 57
Campral 58
Antabuse 60
Side Effects of Antabuse 60
Methadone 61
Study Related to Methadone 62
Treatment 62
Treatment Risks 62
Suboxone 63
Others 64
Chapter 6: Global Substance Abuse and Addiction Treatment Market, Breakdown
by Region 66
North America 66
The United States 68
Mexico 76
Canada 83
Europe 85
The United Kingdom 87
Germany 90
France 93
Italy 96
Spain 97
Russia 98
Rest of Europe 98
Asia-Pacific 101
India 103
Japan 105
China 106
Australia 107
Rest of Asia-Pacific 109
ROW 110
Latin America 111
The Middle East 114
Africa 115
Chapter 7: Patent Review 118
Patent Review by Year 118
Patent Review by Region 118
Patent Review by Applicant 119
Patent Review for Substance Abuse 120
Chapter 8: Global Substance Abuse and Addiction Treatment Market
Opportunities Analysis 122
Product Approval 123
Collaborations 124
Acquisitions 125
Product Launches 126
Chapter 9: Company Profiles 129
Appendix: Lists of Patents 149
List of Patents in North America 149
List of Patents in Europe 151
List of Patents in Asia-Pacific 151
List of Patents in the ROW 153
List of Abbreviations 154
About BCC Research 156
About BCC Research 157
BCC Membership 157
BCC Custom Research 157

List of Tables

Summary Table: Global Market for Substance Abuse and Addiction Treatment, by Condition, Through 2021 ($ Millions) 10
Table 1 Advantages and Disadvantages of Point-of-Care Testing 20
Table 2 Major Advantages and Disadvantages of On-site Testing 21
Table 3 Drug Abuse Statistics in the U.S. by Drug Type (12 Yrs. and Older), 2011 and 2012 (Thousands) 23
Table 4 Lifetime Illicit Drug Use Among Persons 12 Yrs. and Older in the U.S., by Age, 2011 and 2012 (Thousands) 24
Table 5 Lifetime Illicit Drug Use Among Persons 12 Yrs. and Older in the U.S. by Gender, Race and Ethnicity, 2011 and 2012 (Thousands) 25
Table 6 Lifetime Illicit Drug Use Among Persons Aged 12 or Older by Gender, Race, Education and Employment, 2011 and 2012 (Thousands) 26
Table 7 Contaminants Found in Drugs 41
Table 8 Search Engine Results for Major Controllers of Captagon in E-Commerce 41
Table 9 Online Markets on the Dark Web for Captagon E-Commerce 43
Table 10 Manufacturers of Captagon and Country Location 43
Table 11 Global Market for Substance Abuse and Addiction Treatment, by Condition, Through 2021 ($ Millions) 49
Table 12 Global Substance Abuse and Addiction Treatment Market for Nicotine Abuse, by Region, Through 2021 ($ Millions) 50
Table 13 Global Substance Abuse and Addiction Treatment Market for Alcohol Abuse, by Region, Through 2021 ($ Millions) 51
Table 14 Global Substance Abuse and Addiction Treatment Market for Drug Abuse, by Type, Through 2021 ($ Millions) 52
Table 15 Global Substance Abuse and Addiction Treatment Market for Drug Abuse, by Region, Through 2021 ($ Millions) 52
Table 16 Global Substance Abuse and Addiction Treatment Market, by Type, Through 2021 ($ Millions) 55
Table 17 Global Substance Abuse and Addiction Treatment Market for Chantix, by Region, Through 2021 ($ Millions 56
Table 18 Global Substance Abuse and Addiction Treatment Market for Zyban, by Region, Through 2021 ($ Millions) 57
Table 19 Global Substance Abuse and Addiction Treatment Market for Detoxification Treatment, by Region, Through 2021 ($ Millions) 58
Table 20 Global Substance Abuse and Addiction Treatment Market or Campral Treatment, by Region, Through 2021 ($ Millions) 59
Table 21 Global Substance Abuse and Addiction Treatment Market for Antabuse, by Region, Through 2021 ($ Millions) 61
Table 22 Global Substance Abuse and Addiction Treatment Market for Methadone, by Region, Through 2021 ($ Millions) 63
Table 23 Global Substance Abuse and Addiction Treatment Market for Suboxone, by Region, Through 2021 ($ Millions) 64
Table 24 Global Substance Abuse and Addiction Treatment Market for other Treatment Types, by Region, Through 2021 ($ Millions) 64
Table 25 Global Market for Substance Abuse and Addiction Treatment, by Region, Through 2021 ($ Millions) 66

If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.